abstract |
The present invention relates to the following general formula I [Chemical 1] , (I) A new CGRP antagonist (wherein R 1 , R 2 , R 3 , R a , R b , R c , X, Y, and Z are as defined below), its individual diastereomers, It relates to the individual enantiomers and salts thereof, in particular physiologically acceptable salts with inorganic or organic acids or bases, drugs comprising said compounds, their use and methods for their preparation. [Selection figure] None |